The GSK (LSE: GSK) share price is a nightmare and there’s little sign of respite ... I remember the glory days when, as ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

The user of the website is referred to as "you" and "your". By posting on our share chat boards you are agreeing to the following: If you are going to post non-English, please also post an English ...

1995 Jan 24, 1995 Sep 28, 1995 Bonus Ratio: 1 share(s) for every 1 shares held Rights May 21, 1993 Jun 15, 1993 Sep 30, 1993 Rights ratio: 1 share for every 5 held at a price of Rs 65.0 Bonus--Jun 23, ...

Sensex, Nifty, Share Prices Highlights: The benchmark equity indices closed on a higher note during Monday’s trading session.

The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...

Currently, GSK plc (ADR)’s price-earnings ratio is 16.1. GSK plc (ADR)’s trailing ... Analysts expect adjusted earnings to reach $4.089 per share for the current fiscal year. GSK plc (ADR) currently ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

Moderna jolted investors by pushing back its profitability forecast two years, to 2028, and announcing a $1.1 billion cut in R&D spending.

Jason Chapman, a seasoned executive known for driving business transformation and leading global go-to-market teams, has been appointed as Interim Global Head of Sales and Marketing. Chapman takes ...

Lexington ranks in the top 10 among mid-size U.S. cities for attracting Generation Z graduates to live and begin their work ...